Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIB Pre-Surgical Trial of Oral Tamoxifen Versus Transdermal 4-hydroxytamoxifen in Women With DCIS of the Breast

NCT02993159 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT02993159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02993159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIB Pre-Surgical Trial of Oral Tamoxifen Versus Transdermal 4-hydroxytamoxifen in Women With DCIS of the Breast
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2017
Completion date
January 24, 2022
Enrollment
100 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

ductal breast carcinoma in situ, estrogen receptor positive